New drug combo shows promise for advanced prostate cancer in both black and white men
NCT ID NCT03098836
First seen Nov 01, 2025 · Last updated May 26, 2026 · Updated 31 times
Summary
This study looked at how well a combination of two drugs (apalutamide and abiraterone) works in Black and White men with advanced prostate cancer that has spread and is no longer responding to hormone therapy. 93 men took the drugs daily, and researchers tracked how long the cancer stayed under control. The goal was to see if there are differences in treatment response between racial groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Chesapeake Urology Associates
Baltimore, Maryland, 21204, United States
-
Duke Cancer Center Cary
Cary, North Carolina, 27518, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Johnston Hematology and Oncology of Clayton
Clayton, North Carolina, 27520, United States
-
Johnston Memorial Hospital
Smithfield, North Carolina, 27577, United States
-
Maria Parham Hospital
Henderson, North Carolina, 27536, United States
-
Scotland Memorial Hospital
Laurinburg, North Carolina, 28352, United States
-
Southeastern Regional
Lumberton, North Carolina, 28358, United States
-
Spartanburg Regional
Spartanburg, South Carolina, 29303, United States
-
Tulane University
New Orleans, Louisiana, 70112, United States
-
UNC Lineberger Cancer Center
Chapel Hill, North Carolina, 27514, United States
-
Virginia Oncology Associates
Hampton, Virginia, 29303, United States
-
Virginia Oncology Associates
Norfolk, Virginia, 23502, United States
Conditions
Explore the condition pages connected to this study.